Walleye Trading
CLVS

Walleye Trading’s Clovis Oncology, Inc. CLVS Stock Holding History

Walleye Trading’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-14,200
Closed -$29K – 5890
2022
Q1 		$29K Buy
14,200
+3,800
+37% +$7.46K ﹤0.01% 4673
2021
Q4 		$28K Sell
10,400
-19,600
-65% -$72.5K ﹤0.01% 4842
2021
Q3 		$134K Buy
30,000
+23,400
+355% +$113K ﹤0.01% 4199
2021
Q2 		$38K Sell
6,600
-6,000
-48% -$35.2K ﹤0.01% 4700
2021
Q1 		$88K Sell
12,600
-1,200
-9% -$8.05K ﹤0.01% 4153
2020
Q4 		$66K Sell
13,800
-11,200
-45% -$56.6K ﹤0.01% 4095
2020
Q3 		$146K Buy
25,000
+4,400
+21% +$26.3K ﹤0.01% 3203
2020
Q2 		$139K Sell
20,600
-15,600
-43% -$118K ﹤0.01% 3322
2020
Q1 		$230K Sell
36,200
-67,000
-65% -$537K ﹤0.01% 2497
2019
Q4 		$1.08M Sell
103,200
-26,400
-20% -$192K 0.01% 1742
2019
Q3 		$509K Buy
129,600
+95,900
+285% +$776K ﹤0.01% 2138
2019
Q2 		$501K Buy
33,700
+24,700
+274% +$446K ﹤0.01% 2190
2019
Q1 		$223K Buy
+9,000
New +$226K ﹤0.01% 2944
2018
Q4 		– Sell
-800
Closed -$23K – 5522
2018
Q3 		$23K Sell
800
-25,200
-97% -$976K ﹤0.01% 4804
2018
Q2 		$1.18M Buy
+26,000
New +$1.26M 0.01% 1918

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Walleye Trading's CLVS Position: Q1 2022 in Review

Walleye Trading sold out of Clovis Oncology, Inc. (CLVS) in Q1 2022, closing a stake of 29,731 shares — an estimated $58.4K sold.

Walleye Trading first reported a position in CLVS in Q3 2015 and held it in 10 quarters. The position peaked at $671K in Q2 2019. 153 funds tracked by Wall St. Rank hold CLVS as of Q1 2022.

  • Walleye Trading reported no remaining Clovis Oncology, Inc. position as of Q1 2022 after selling out during the quarter.
  • Walleye Trading sold 29,731 Clovis Oncology, Inc. shares in Q1 2022, an estimated $58.4K.
  • Walleye Trading first reported a position in Clovis Oncology, Inc. in Q3 2015 and held it in 10 quarters.
  • Walleye Trading's Clovis Oncology, Inc. position peaked at $671K in Q2 2019.
  • 153 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2022.

Based on Walleye Trading's 13F filing for Q1 2022, filed 16 May 2022.